Pneumonia Diagnostics Market
Explore the Role of Pneumonia Diagnostics in Tackling the Global Burden of Pneumonia With FMI’s New Edition!
Pneumonia Diagnostics Market by Product & Region | Forecast 2022 to 2032
Pneumonia Diagnostics Market Outlook (2022 to 2032)
[276 Pages Report] The global pneumonia diagnostics market is expected to enjoy a valuation of US$ 521.1 Million by the end of 2022, and further expand at a CAGR of 5.6% from 2022 to 2032, reaching a valuation of ~US$ 899.4 Million by 2032. The rising prevalence of pneumonia along with the growing need for early detection of this medical condition for initiating a proper treatment is a key factor driving demand for pneumonia diagnostics in the market.
Based on product, the streptococcus-based segment dominated the global pneumonia diagnostics market with a share of about 36.2% in 2021 and the trend is likely to continue during the assessment period. The overall pneumonia diagnostics market constituted approximately 0.6% of the global in vitro diagnostics market which stood at ~US$ 76.3 Billion in 2021.
|
Attribute |
Key Insights |
|
Pneumonia Diagnostics Market Base Value (2021) |
US$ 492.2 Million |
|
Estimated Market Value (2022) |
US$ 521.1 Million |
|
Projected Market Value (2032) |
US$ 899.4 Million |
|
Value-based CAGR (2022 to 2032) |
5.6% |
|
Market Share of Top 5 Countries |
43.9% |
Pneumonia continues to be a worldwide health concern with a high morbidity and fatality rate. Identifying the microbial pathogens that cause lung infection is crucial for optimal clinical care of pneumonia patients and is a significant barrier to conventional microbiological approaches.
In recent years, the discovery and deployment of molecular diagnostic assays for pneumonia have resulted in a significant improvement in the microbiological detection of respiratory pathogens. However, with new information about the microbiome and lungs presenting a dynamic microbiological ecosystem, our present notion of pneumonia is no longer completely practical, because this new idea of pneumonia entails modification of the lung microbiome.
Pneumonia diagnostics refers to solutions used to identify and detect pneumonia-causing agents like streptococcus, legionella, chlamydophilla, mycoplasma, etc. They are being increasingly utilized to detect pneumonia, especially during its early stages, to initiate a proper treatment approach.
Growing focus on reducing the mortality rate of pneumonia will therefore continue to boost the global pneumonia diagnostics market during the forecast period.
Similarly, increasing health awareness and availability of advanced diagnostic products will further accelerate growth in the market during the assessment period.
Regionally, North America held the highest market share of 30.6% in 2021 and it is likely to retain its dominance during the forecast period. Factors such as the increasing incidence of infectious diseases, the presence of leading manufacturers, and the availability of advanced products are propelling sales in the USA market.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Pneumonia Diagnostics from 2012 to 2021 Vs Market Outlook for 2022 to 2032
The overall sales in the pneumonia diagnostics market are projected to grow at 5.6% CAGR between 2022 and 2032, in comparison to the 4.5% CAGR registered from 2012 to 2021.
The rising incidence of pneumonia, the growing focus on early detection of infectious diseases, and advancements in diagnostics techniques are some of the key factors driving the global pneumonia diagnostic market.
Lung infections and other infectious diseases are becoming more common, there is an increase in the demand for diagnostics for pneumonia. One type of acute lung infection is pneumonia. A healthy person's lungs are made up of tiny sacs called alveoli that are filled with air as they breathe. Pneumonia causes the alveoli to bloat up with pus and fluid, which makes breathing challenging and limits oxygen intake.
The most common infectious cause of death in children worldwide is pneumonia. According to the World Health Organization 2021, pneumonia caused 740 to 180 deaths below the age of five in 2019, contributing to 14% of all deaths in children under the age of five but 22% of all deaths in children aged 1 to 5. Pneumonia affects children and families worldwide, although mortality is highest in Sub-Saharan Africa and South Asia.
The increasing adoption of point-of-care diagnostics and development in the detection of nucleic acid around the globe are set to boost the market in the given forecast period.
These factors, combined with the growing tendency toward preventive care are projected to increase the demand for pneumonia diagnostics products over the forecast period.
What are the Key Trends Driving the Global Pneumonia Diagnostics Market?
Rising Government Initiatives and Advancements in Diagnostic Technologies to Boost Market Over the Next Decade
The global pneumonia diagnostics market is likely to witness healthy growth owing to the increasing investments and initiatives by governments in emerging countries to modernize healthcare infrastructure.
The broad availability of rapid molecular diagnostic testing offers an unprecedented insight into pneumonia etiologies, challenging paradigms established by previous investigations from microbiological cultures.
Microscopy and culture of blood cultures, respiratory tract specimens, detection of antigens in urine and respiratory specimens, and detection of specific antibodies in the blood continue to be used in the routine laboratory evaluation of patients with pneumonia (serology). Nucleic acid detection technologies, such as polymerase chain reaction (PCR), have been available for more than two decades and are now commonplace in tertiary-level diagnostic laboratories.
Advancements in current diagnostics and innovation will thrive in the market in near future. For instance, Massachusetts Institute of Technology researchers have developed a sensor that can differentiate between viral and bacterial pneumonia infections, which they hope may aid doctors in selecting the best therapy.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich are the Factors Restraining Growth of the Pneumonia Diagnostics Market?
The pricing pressure due to competition and difficulty in diagnosing can hamper the growth of the pneumonia diagnostics market during the forecast period.
In the community environment, the diagnosis and management of pneumonia usually become extremely complex. Physician approaches are primarily dependent on diagnosis information. In some circumstances, false positive results result in catastrophic patient mismanagement with antibiotics, as well as the possibility of superinfection and medication complications.
Immunoassay approaches for diagnosis are promising, however, they are still insufficient to screen for a wide range of pathogens. All these factors act as restraints in the growth of the pneumonia diagnostics market.
Similarly, low healthcare awareness across lower economies along with inadequate reimbursement policies is emerging as a significant impediment to the development of the pneumonia diagnostics market.
Country-wise Insights
Why is the USA Considered a Prominent Pneumonia Diagnostics Market?
Increasing Incidence of Pneumonia and High Diagnostic Rates Driving Market in the USA
The USA dominated the North American pneumonia diagnostics market with a total market share of about 84.0% in 2021 and it is likely to expand at a steady pace during the forecast period.
Growth in the USA pneumonia diagnostics market is driven by the rising prevalence of pneumonia, increasing diagnostic screening rates due to high levels of awareness among people, and the presence of leading manufacturers.
Over the years, there has been a significant rise in the cases of pneumonia and pneumonia-related deaths across the USA which has necessitated the adoption of pneumonia diagnostics.
For instance, as per the Centers for Disease Control and Prevention (CDC), around 25.5% of USA adults suffered from pneumonia in 2020 while the total number of pneumonia-related deaths reached 47,601. In order to tackle this, people opt for various diagnostic tests and treatments. This will continue to boost the pneumonia diagnostics market in the country during the next ten years.
Similarly, increasing healthcare care spending and the presence of favourable reimbursement policies will further boost the demand for pneumonia diagnostic products in the USA market over the assessment period.
What Makes Canada a Highly Lucrative Pneumonia Diagnostics Market?
Easy Availability of Pneumonia Diagnostics Products Fuelling Sales in Canada
Canada held approximately 16.0% share in the North American pneumonia diagnostics market in 2021 and it is projected to display a growth rate of around 6.3% CAGR during the forecast period.
Growth in Canada’s pneumonia diagnostics market is projected to be driven by increasing production of pneumonia diagnostics products by top players, surging cases of pneumonia infection, and rising health awareness among people.
Favourable government support and the availability of better treatment approaches will further boost the market in the country over the next decade.
What is the Demand Outlook for Germany’s Pneumonia Diagnostics Market?
Continuous Advancements in Diagnostics Technologies to Boost Market in Germany
As per FMI, the overall pneumonia diagnostics market in Germany is set to exhibit a CAGR of nearly 7.5% during the forecast period (2022 to 2032). Germany is becoming increasingly popular when it comes to health and innovation.
With the increasing prevalence of chronic diseases and rising geriatric population demand for pneumonia diagnostics products will grow at a robust pace across Germany during the forecast period.
Similarly, the flourishing medical tourism sector and advancements in diagnostic technology will bode well for Germany’s pneumonia diagnostics market over the next ten years.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which is the Most Commonly Used Product in the Global Market?
Demand to Remain High for Streptococcus-Based Diagnostic Products
As per FMI, the streptococcus-based diagnostic products segment held the largest market share of about 36.2% in 2021 and it is expected to grow at a CAGR of 5.6% throughout the forecast period. This can be attributed to the rising prevalence of pneumococcal diseases and the increasing usage of streptococci-based diagnostic products for detecting this disease.
Streptococci are typically cultured on blood-supplemented agar media. This approach detects haemolysis, which is necessary for further identification procedures, and increases streptococci growth by introducing an external supply of catalase. Since this strain is the most common cause of pneumonia, this segment is set to drive the growth of the overall market.
Competitive Landscape
With several competitors in the pneumonia diagnostics production sphere, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
Instances of key developmental strategies by the industry players in the pneumonia diagnostics market are given below:
- In February 2022, Cue Health Inc., a healthcare technology business, and Cardinal Health announced the extended distribution of Cue's COVID-19 tests for professional usage and over-the-counter use. Cue chose Cardinal Health as one of its key distributors because of its demonstrated ability in assisting diagnostic technology commercialization. Cardinal Health serves almost 90% of US hospitals and over 60,000 pharmacies. This collaboration will assist Cue's breakthrough nucleic acid amplification test (NAAT) gain traction in both standard and non-traditional healthcare settings.
- In November 2018, bioMerieux received the Food and Drug Administration (FDA) clearance for the BIOFIRE FILMARRAY Pneumonia Panels.
Report Scope as per Pneumonia Diagnostics Industry Analysis
|
Attribute |
Details |
|
Estimated Market Size (2022) |
US$ 521.1 Million |
|
Projected Market Size (2032) |
US$ 899.4 Million |
|
Anticipated Growth Rate (2022 to 2032) |
5.6% |
|
Forecast Period |
2012 to 2021 |
|
Historical Data Available for |
2022 to 2032 |
|
Market Analysis |
US$ Million for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Israel, Turkey, GCC Countries, and South Africa |
|
Key Market Segments Covered |
Product and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Key Market Segments Covered in Pneumonia Diagnostics Industry Research
By Product:
- Streptococcus based
- Legionella based
- Chlamydophilla based
- Mycoplasma Pneumonia based
- Viral Pneumonia based
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
What is the current size of the pneumonia diagnostics market?
The global pneumonia diagnostics market size reached US$ 492.2 Million in 2021 and is likely to touch a valuation of US$ 521.1 Million in 2022.
What is the sales forecast for the pneumonia diagnostics market through 2032?
The pneumonia diagnostics market is expected to reach US$ 899.4 Million by the end of 2032, with sales revenue expected to grow at 5.6% CAGR throughout the forecast period.
What are the key trends shaping the pneumonia diagnostics industry?
Growing adoption by the increasing geriatric population, innovative product development, and increasing prevalence of infectious diseases are some of the key trends in this market.
Which are the top five countries driving demand for pneumonia diagnostics products?
The USA, Canada, China, Germany, and the UK are driving demand for pneumonia diagnostics products.
How big is the USA pneumonia diagnostics?
The USA accounted for about 84.0% of the North American pneumonia diagnostics market in 2021.
At what rate is the demand for pneumonia diagnostics expected to grow in Europe?
Demand for pneumonia diagnostics in Europe is expected to grow at 7.5% CAGR over the next ten years.
Which countries are the key producers of pneumonia diagnostics?
The USA, China, and Germany are the key producers of pneumonia diagnostics.
Who are the key players in the pneumonia diagnostics market sphere?
Thermo Fisher Scientific Inc., Alere Inc., Quidel Corporation, Becton, Dickinson and Company, Meridian Bioscience, Inc, Qiagen N.V., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., Beckman Coulter Inc (Danaher Corporation), Hologic Inc., La Roche Ltd., Abbot Laboratories, Quest Diagnostics, and Luminex Corporation are some of the key players in the pneumonia diagnostics industry.
What is the demand outlook for pneumonia diagnostics market in Japan?
The pneumonia diagnostics market in Japan is set to expand at a CAGR of 5.5% during the forecast years.
What is the growth projection for China’s pneumonia diagnostics market?
The overall pneumonia diagnostics market in China is set to expand at a CAGR of 6.4% during the forecast period.
Table of Content
1. Executive Summary | Pneumonia Diagnostics Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Respiratory Disease Epidemiology 4.2. Product Adoption /Usage Analysis 4.3. Value Chain Analysis 4.4. Key Promotional Strategies, By Manufacturers 4.5. Regulatory Scenario 4.6. Porter’s Analysis 4.7. PESTLE Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare GDP Growth Outlook 5.1.3. Global In Vitro Diagnostics Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Historical Growth of Key Players 5.2.2. Cost of Product 5.2.3. Product Launches 5.2.4. Research and Development Expenditure by Key Players 5.2.5. Technological Advancements 5.2.6. Product Adoption Rate 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Product, 6.1.2. Revenue By Region 6.2. 2021 Market Scenario 7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2021 8.3. Current and Future Market Size (US$ Million) and Analysis and Forecast By Product, 2022 to 2032 8.3.1. Streptococcus based 8.3.2. Legionella based 8.3.3. Chlamydophilla based 8.3.4. Mycoplasma Pneumonia based 8.3.5. Viral Pneumonia based 8.4. Market Attractiveness Analysis By Product 9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region 9.1. Introduction 9.2. Pricing Analysis 9.3. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021 9.4. Current and Future Market Size (US$ Million) and Analysis and Forecast By Region, 2022 to 2032 9.4.1. North America 9.4.2. Latin America 9.4.3. Europe 9.4.4. East Asia 9.4.5. South Asia 9.4.6. Oceania 9.4.7. Middle East and Africa (MEA) 9.5. Market Attractiveness Analysis By Region 10. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 10.1. Introduction 10.2. Pricing Analysis 10.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 10.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 10.4.1. By Country 10.4.1.1. United States of America 10.4.1.2. Canada 10.4.2. By Product 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Product 10.6. Market Trends 10.7. Key Market Participants - Intensity Mapping 10.8. Drivers and Restraints - Impact Analysis 10.9. Country-Level Analysis & Forecast 10.9.1. USA Market Analysis 10.9.1.1. Introduction 10.9.1.2. Market Analysis and Forecast by Market Taxonomy 10.9.1.2.1. By Product 10.9.2. Canada Market Analysis 10.9.2.1. Introduction 10.9.2.2. Market Analysis and Forecast by Market Taxonomy 10.9.2.2.1. By Product 11. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 11.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 11.4.1. By Country 11.4.1.1. Mexico 11.4.1.2. Brazil 11.4.1.3. Argentina 11.4.1.4. Rest of Latin America 11.4.2. By Product 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Product 11.6. Market Trends 11.7. Key Market Participants - Intensity Mapping 11.8. Drivers and Restraints - Impact Analysis 11.9. Country-Level Analysis & Forecast 11.9.1. Mexico Market Analysis 11.9.1.1. Introduction 11.9.1.2. Market Analysis and Forecast by Market Taxonomy 11.9.1.2.1. By Product 11.9.2. Brazil Market Analysis 11.9.2.1. Introduction 11.9.2.2. Market Analysis and Forecast by Market Taxonomy 11.9.2.2.1. By Product 11.9.3. Argentina Market Analysis 11.9.3.1. Introduction 11.9.3.2. Market Analysis and Forecast by Market Taxonomy 11.9.3.2.1. By Product 12. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 12.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1. Germany 12.4.1.2. Italy 12.4.1.3. France 12.4.1.4. United Kingdom 12.4.1.5. Spain 12.4.1.6. BENELUX 12.4.1.7. Russia 12.4.1.8. Rest of Europe 12.4.2. By Product 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 12.9. Country-Level Analysis & Forecast 12.9.1. Germany Market Analysis 12.9.1.1. Introduction 12.9.1.2. Market Analysis and Forecast by Market Taxonomy 12.9.1.2.1. By Product 12.9.2. Italy Market Analysis 12.9.2.1. Introduction 12.9.2.2. Market Analysis and Forecast by Market Taxonomy 12.9.2.2.1. By Product 12.9.3. France Market Analysis 12.9.3.1. Introduction 12.9.3.2. Market Analysis and Forecast by Market Taxonomy 12.9.3.2.1. By Product 12.9.4. UK Market Analysis 12.9.4.1. Introduction 12.9.4.2. Market Analysis and Forecast by Market Taxonomy 12.9.4.2.1. By Product 12.9.5. Spain Market Analysis 12.9.5.1. Introduction 12.9.5.2. Market Analysis and Forecast by Market Taxonomy 12.9.5.2.1. By Product 12.9.6. BENELUX Market Analysis 12.9.6.1. Introduction 12.9.6.2. Market Analysis and Forecast by Market Taxonomy 12.9.6.2.1. By Product 12.9.7. Nordic Countries Market Analysis 12.9.7.1. Introduction 12.9.7.2. Market Analysis and Forecast by Market Taxonomy 12.9.7.2.1. By Product 12.9.8. Russia Market Analysis 12.9.8.1. Introduction 12.9.8.2. Market Analysis and Forecast by Market Taxonomy 12.9.8.2.1. By Product 13. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 13.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. China 13.4.1.2. Japan 13.4.1.3. South Korea 13.4.2. By Product 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 13.9. Country-Level Analysis & Forecast 13.9.1. China Market Analysis 13.9.1.1. Introduction 13.9.1.2. Market Analysis and Forecast by Market Taxonomy 13.9.1.2.1. By Product 13.9.2. Japan Market Analysis 13.9.2.1. Introduction 13.9.2.2. Market Analysis and Forecast by Market Taxonomy 13.9.2.2.1. By Product 13.9.3. South Korea Market Analysis 13.9.3.1. Introduction 13.9.3.2. Market Analysis and Forecast by Market Taxonomy 13.9.3.2.1. By Product 14. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 14.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. India 14.4.1.2. Indonesia 14.4.1.3. Malaysia 14.4.1.4. Thailand 14.4.1.5. Philippines 14.4.1.6. Vietnam 14.4.1.7. Rest of South Asia 14.4.2. By Product 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country-Level Analysis & Forecast 14.9.1. India Market Analysis 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Product 14.9.2. Indonesia Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Product 14.9.3. Malaysia Market Analysis 14.9.3.1. Introduction 14.9.3.2. Market Analysis and Forecast by Market Taxonomy 14.9.3.2.1. By Product 14.9.4. Thailand Market Analysis 14.9.4.1. Introduction 14.9.4.2. Market Analysis and Forecast by Market Taxonomy 14.9.4.2.1. By Product 14.9.5. Philippines Market Analysis 14.9.5.1. Introduction 14.9.5.2. Market Analysis and Forecast by Market Taxonomy 14.9.5.2.1. By Product 14.9.6. Vietnam Market Analysis 14.9.6.1. Introduction 14.9.6.2. Market Analysis and Forecast by Market Taxonomy 14.9.6.2.1. By Product 15. Oceania Market 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 15.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. Australia 15.4.1.2. New Zealand 15.4.2. By Product 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country-Level Analysis & Forecast 15.8.1. Australia Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.2. New Zealand Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 16. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2021 16.4. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. Turkey 16.4.1.3. Israel 16.4.1.4. South Africa 16.4.1.5. North Africa 16.4.1.6. Rest of Middle East and Africa 16.4.2. By Product 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country-Level Analysis & Forecast 16.9.1. GCC Countries Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Product 16.9.2. Turkey Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Product 16.9.3. Israel Market Analysis 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Product 16.9.4. South Africa Market Analysis 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Product 16.9.5. North Africa Market Analysis 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Product 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Share Analysis of Top Players 17.3. Market Presence Analysis 17.3.1. By Regional Footprint of Players 17.3.2. Product Footprint of Players 17.3.3. Channel Footprint of Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive (Tentative List) 18.3.1. Thermo Fisher Scientific Inc. 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Key Financials 18.3.1.4. Sales Footprint 18.3.1.5. SWOT Analysis 18.3.1.6. Strategy Overview 18.3.2. Alere Inc., 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Key Financials 18.3.2.4. Sales Footprint 18.3.2.5. SWOT Analysis 18.3.2.6. Strategy Overview 18.3.3. Quidel Corporation, 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Key Financials 18.3.3.4. Sales Footprint 18.3.3.5. SWOT Analysis 18.3.3.6. Strategy Overview 18.3.4. Becton, Dickinson, and Company, 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Key Financials 18.3.4.4. Sales Footprint 18.3.4.5. SWOT Analysis 18.3.4.6. Strategy Overview 18.3.5. Meridian Bioscience, Inc, 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Key Financials 18.3.5.4. Sales Footprint 18.3.5.5. SWOT Analysis 18.3.5.6. Strategy Overview 18.3.6. Qiagen N.V., 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Key Financials 18.3.6.4. Sales Footprint 18.3.6.5. SWOT Analysis 18.3.6.6. Strategy Overview 18.3.7. bioMérieux SA, 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Key Financials 18.3.7.4. Sales Footprint 18.3.7.5. SWOT Analysis 18.3.7.6. Strategy Overview 18.3.8. Bio-Rad Laboratories Inc., 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Key Financials 18.3.8.4. Sales Footprint 18.3.8.5. SWOT Analysis 18.3.8.6. Strategy Overview 18.3.9. Cardinal Health Inc., 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Key Financials 18.3.9.4. Sales Footprint 18.3.9.5. SWOT Analysis 18.3.9.6. Strategy Overview 18.3.10. Beckman Coulter Inc (Danaher Corporation), 18.3.10.1. Overview 18.3.10.2. Product Portfolio 18.3.10.3. Key Financials 18.3.10.4. Sales Footprint 18.3.10.5. SWOT Analysis 18.3.10.6. Strategy Overview 18.3.11. Hologic Inc., 18.3.11.1. Overview 18.3.11.2. Product Portfolio 18.3.11.3. Key Financials 18.3.11.4. Sales Footprint 18.3.11.5. SWOT Analysis 18.3.11.6. Strategy Overview 18.3.12. La Roche Ltd. 18.3.12.1. Overview 18.3.12.2. Product Portfolio 18.3.12.3. Key Financials 18.3.12.4. Sales Footprint 18.3.12.5. SWOT Analysis 18.3.12.6. Strategy Overview 18.3.13. Abbot Laboratories, 18.3.13.1. Overview 18.3.13.2. Product Portfolio 18.3.13.3. Key Financials 18.3.13.4. Sales Footprint 18.3.13.5. SWOT Analysis 18.3.13.6. Strategy Overview 18.3.14. Quest Diagnostics, 18.3.14.1. Overview 18.3.14.2. Product Portfolio 18.3.14.3. Key Financials 18.3.14.4. Sales Footprint 18.3.14.5. SWOT Analysis 18.3.14.6. Strategy Overview 18.3.15. Luminex Corporation. 18.3.15.1. Overview 18.3.15.2. Product Portfolio 18.3.15.3. Key Financials 18.3.15.4. Sales Footprint 18.3.15.5. SWOT Analysis 18.3.15.6. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 02: Global Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 03: Global Market Value (US$ Million) Analysis 2012 to 2021, By Region Table 04: Global Market Value (US$ Million) Forecast 2022 to 2032, By Region Table 05: North America Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 06: North America Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 07: North America Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 08: North America Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 09: North America Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 10: North America Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 11: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 12: Latin America Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 13: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 14: Latin America Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 15: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 16: Europe Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 17: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 18: Europe Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 19: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 20: East Asia Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 21: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 22: East Asia Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 23: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 24: South Asia Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 25: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 26: South Asia Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 27: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 20 Table 28: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 20 Table 29: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 30: Oceania Market Value (US$ Million) Forecast 2022 to 2032, By Product Table 31: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021, By Country Table 32: Middle East & Africa Market Value (US$ Million) Forecast 2022 to 2032, By Country Table 33: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021, By Product Table 34: Middle East & Africa Market Value (US$ Million) Forecast 2022 to 2032, By Product
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value, 2012 to 2021 Figure 02: Global Market Value (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 03: Global Market Absolute $ Opportunity, 2022 to 2032 Figure 04: Global Market Share Analysis (%) by Product, 2022 to 2032 Figure 05: Global Market Y-o-Y Growth Projections By Product, 2022 to 2032 Figure 06: Global Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 07: Global Market Share Analysis (%) by Region 2022 to 2032 Figure 08: Global Market Y-o-Y Growth Projections By Region, 2022 to 2032 Figure 09: Global Market Attractiveness Analysis, By Region, 2022 to 2032 Figure 10: North America Market Share, By Product, 2022 (E) Figure 11: North America Market Share, By Country, 2022 (E) Figure 12: North America Market Size (US$ Million) Analysis, 2012 to 2021 Figure 13: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 14: North America Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 15: North America Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 16: USA Market Value Proportion Analysis, 2021 Figure 17: Global Vs USA Y-o-Y Growth Comparison, 2021 to 2032 Figure 18: USA Market Share Analysis (%) by Product, 2021 to 2032 Figure 19: Canada Market Value Proportion Analysis, 2021 Figure 20: Global Vs Canada Y-o-Y Growth Comparison, 2021 to 2032 Figure 21: Canada Market Share Analysis (%) by Product, 2021 to 2032 Figure 22: Latin America Market Share, By Product, 2022 (E) Figure 23: Latin America Market Share, By Country, 2022 (E) Figure 24: Latin America Market Size (US$ Million) Analysis, 2012 to 2021 Figure 25: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 26: Latin America Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 27: Latin America Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 28: Brazil Market Value Proportion Analysis, 2021 Figure 29: Global Vs Brazil Y-o-Y Growth Comparison, 2021 to 2032 Figure 30: Brazil Market Share Analysis (%) by Product, 2021 to 2032 Figure 31: Mexico Market Value Proportion Analysis, 2021 Figure 32: Global Vs Mexico Y-o-Y Growth Comparison, 2021 to 2032 Figure 33: Mexico Market Share Analysis (%) by Product, 2021 to 2032 Figure 34: Argentina Market Value Proportion Analysis, 2021 Figure 35: Global Vs Argentina Y-o-Y Growth Comparison, 2021 to 2032 Figure 36: Argentina Market Share Analysis (%) by Product, 2021 to 2032 Figure 37: Europe Market Share, By Product, 2022 (E) Figure 38: Europe Market Share, By Country, 2022 (E) Figure 39: Europe Market Size (US$ Million) Analysis, 2012 to 2021 Figure 40: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 41: Europe Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 42: Europe Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 43: Germany Market Value Proportion Analysis, 2021 Figure 44: Global Vs Germany Y-o-Y Growth Comparison, 2021 to 2032 Figure 45: Germany Market Share Analysis (%) by Product, 2021 to 2032 Figure 46: Italy Market Value Proportion Analysis, 2021 Figure 47: Global Vs Italy Y-o-Y Growth Comparison, 2021 to 2032 Figure 48: Italy Market Share Analysis (%) by Product, 2021 to 2032 Figure 49: France Market Value Proportion Analysis, 2021 Figure 50: Global Vs France Y-o-Y Growth Comparison, 2021 to 2032 Figure 51: France Market Share Analysis (%) by Product, 2021 to 2032 Figure 52: UK Market Value Proportion Analysis, 2021 Figure 53: Global Vs UK Y-o-Y Growth Comparison, 2021 to 2032 Figure 54: UK Market Share Analysis (%) by Product, 2021 to 2032 Figure 55: Spain Market Value Proportion Analysis, 2021 Figure 56: Global Vs Spain Y-o-Y Growth Comparison, 2021 to 2032 Figure 57: Spain Market Share Analysis (%) by Product, 2021 to 2032 Figure 58: BENELUX Market Value Proportion Analysis, 2021 Figure 59: Global Vs BENELUX Y-o-Y Growth Comparison, 2021 to 2032 Figure 60: BENELUX Market Share Analysis (%) by Product, 2021 to 2032 Figure 61: Nordic Countries Market Value Proportion Analysis, 2021 Figure 62: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2021 to 2032 Figure 63: Nordic Countries Market Share Analysis (%) by Product, 2021 to 2032 Figure 64: Russia Market Value Proportion Analysis, 2021 Figure 65: Global Vs Russia Y-o-Y Growth Comparison, 2021 to 2032 Figure 66: Russia Market Share Analysis (%) by Product, 2021 to 2032 Figure 67: East Asia Market Share, By Product, 2022 (E) Figure 68: East Asia Market Share, By Country, 2022 (E) Figure 69: East Asia Market Size (US$ Million) Analysis, 2012 to 2021 Figure 70: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 71: East Asia Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 72: East Asia Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 73: China Market Value Proportion Analysis, 2021 Figure 74: Global Vs China Y-o-Y Growth Comparison, 2021 to 2032 Figure 75: China Market Share Analysis (%) by Product, 2021 to 2032 Figure 76: Japan Market Value Proportion Analysis, 2021 Figure 77: Global Vs Japan Y-o-Y Growth Comparison, 2021 to 2032 Figure 78: Japan Market Share Analysis (%) by Product, 2021 to 2032 Figure 79: South Korea Market Value Proportion Analysis, 2021 Figure 80: Global Vs South Korea Y-o-Y Growth Comparison, 2021 to 2032 Figure 81: South Korea Market Share Analysis (%) by Product, 2021 to 2032 Figure 82: South Asia Market Share, By Product, 2022 (E) Figure 83: South Asia Market Share, By Country, 2022 (E) Figure 84: South Asia Market Size (US$ Million) Analysis, 2012 to 2021 Figure 85: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 86: South Asia Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 87: South Asia Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 88: India Market Value Proportion Analysis, 2021 Figure 89: Global Vs India Y-o-Y Growth Comparison, 2021 to 2032 Figure 90: India Market Share Analysis (%) by Product, 2021 to 2032 Figure 91: Indonesia Market Value Proportion Analysis, 2021 Figure 92: Global Vs Indonesia Y-o-Y Growth Comparison, 2021 to 2032 Figure 93: Indonesia Market Share Analysis (%) by Product, 2021 to 2032 Figure 94: Malaysia Market Value Proportion Analysis, 2021 Figure 95: Global Vs Malaysia Y-o-Y Growth Comparison, 2021 to 2032 Figure 96: Malaysia Market Share Analysis (%) by Product, 2021 to 2032 Figure 97: Thailand Market Value Proportion Analysis, 2021 Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2021 to 2032 Figure 99: Thailand Market Share Analysis (%) by Product, 2021 to 2032 Figure 100: Philippines Market Value Proportion Analysis, 2021 Figure 101: Global Vs Philippines Y-o-Y Growth Comparison, 2021 to 2032 Figure 102: Philippines Market Share Analysis (%) by Product, 2021 to 2032 Figure 103: Vietnam Market Value Proportion Analysis, 2021 Figure 104: Global Vs Vietnam Y-o-Y Growth Comparison, 2021 to 2032 Figure 105: Vietnam Market Share Analysis (%) by Product, 2021 to 2032 Figure 106: Oceania Market Share, By Product, 2022 (E) Figure 107: Oceania Market Share, By Country, 2022 (E) Figure 108: Oceania Market Size (US$ Million) Analysis, 2012 to 2021 Figure 109: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 110: Oceania Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 111: Oceania Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 112: Australia Market Value Proportion Analysis, 2021 Figure 113: Global Vs Australia Y-o-Y Growth Comparison, 2021 to 2032 Figure 114: Australia Market Share Analysis (%) by Product, 2021 to 2032 Figure 115: New Zealand Market Value Proportion Analysis, 2021 Figure 116: Global Vs New Zealand Y-o-Y Growth Comparison, 2021 to 2032 Figure 117: New Zealand Market Share Analysis (%) by Product, 2021 to 2032 Figure 118: Middle East & Africa Market Share, By Product, 2022 (E) Figure 119: Middle East & Africa Market Share, By Country, 2022 (E) Figure 120: Middle East & Africa Market Size (US$ Million) Analysis, 2012 to 2021 Figure 121: Middle East & Africa Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2032 Figure 122: Middle East & Africa Market Attractiveness Analysis, By Product, 2022 to 2032 Figure 123: Middle East & Africa Market Attractiveness Analysis, By Country, 2022 to 2032 Figure 124: GCC Countries Market Value Proportion Analysis, 2021 Figure 125: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021 to 2032 Figure 126: GCC Countries Market Share Analysis (%) by Product, 2021 to 2032 Figure 127: Turkey Market Value Proportion Analysis, 2021 Figure 128: Global Vs Turkey Y-o-Y Growth Comparison, 2021 to 2032 Figure 129: Turkey Market Share Analysis (%) by Product, 2021 to 2032 Figure 130: Israel Market Value Proportion Analysis, 2021 Figure 131: Global Vs Israel Y-o-Y Growth Comparison, 2021 to 2032 Figure 132: Israel Market Share Analysis (%) by Product, 2021 to 2032 Figure 133: South Africa Market Value Proportion Analysis, 2021 Figure 134: Global Vs South Africa Y-o-Y Growth Comparison, 2021 to 2032 Figure 135: South Africa Market Share Analysis (%) by Product, 2021 to 2032 Figure 136: North Africa Market Value Proportion Analysis, 2021 Figure 137: Global Vs North Africa Y-o-Y Growth Comparison, 2021 to 2032 Figure 138: North Africa Market Share Analysis (%) by Product, 2021 to 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
